Study Of 323U66 SR In Major Depressive Disorder
NCT00135512
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
234
Enrollment
INDUSTRY
Sponsor class
Conditions
Depressive Disorder
Interventions
DRUG:
bupropion hydrochloride
Sponsor
GlaxoSmithKline